Table 1.
Characteristics of patients with confirmed bacterial infection.
| Total n = 22 patients |
|
|---|---|
| Characteristics of patients | |
| Age (years), median [IQR] | 69 [52;84] |
| Male sex, n (%) | 19 (86.4) |
| Smoking, n (%) | 13 (59.0) |
| Underlying medical condition, n (%) | 17 (77.3) |
| Chronic lung disease | 9 |
| COPD | 7 |
| Other | 2 |
| Lung bacterial colonization < 3 months | 3 |
| Immunosuppressive disease | 10 |
| Diabetes mellitus | 3 |
| Severe kidney impairment | 3 |
| Other | 4 |
| SARS-CoV-2 infection characteristics | |
| Positive COVID-19 PCR | 22 (100%) |
| Empirical antibiotics, n (%) | 12 (54.6) |
| Immunomodulatory treatment, n (%) | 14 (63.6) |
| Corticosteroids | 14 |
| Anakinra | 6 |
| Other | 2 |
| Initial CT-scan, n (%) | 22 (100%) |
| Parenchymal involvement | |
| ≤ 25% | 11 (50.0%) |
| 25–50% | 7 (31.8%) |
| 50–75% | 1 (4.5%) |
| Atypical | 3 (13.6%) |
| Pulmonary consolidation | 17 (77.3%) |
| Bacterial infection characteristics | |
| Time since COVID-19 onset (days), median [IQR] | 10 [4;21] |
| Clinical signs, n (%) | |
| Increased oxygen requirements | 20 (90.9%) |
| Productive cough or modification of sputum aspect | 17 (77.3%) |
| Fever | 10 (45.0%) |
| Sepsis | 2 (9.1%) |
| Chest pain | 1 (4.5%) |
| Outcome at transfer | |
| Discharged from hospital, n (%) | 9 (40.9%) |
| Death, n (%) | 8 (36.4%) |
| Intensive care, n (%) | 5 (22.7%) |
IQR: interquartile range; COPD: chronic obstructive pulmonary disease.